News

The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.
WASHINGTON — Even before he took over the Food and Drug Administration, Marty Makary called for frequent, transparent meetings of the independent panels that advise the agency on ...
Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...
Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...
With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug ...
Meanwhile, FDA Commissioner Marty Makary highlighted the speed with which the tool was rolled out. "I set an aggressive timeline to scale AI agency-wide by June 30," Makary said.
The Trump administration‘s “Make America Healthy Again” goals depend on negotiations with food and healthcare industry leaders rather than regulation, the heads of the Food and Drug Administration and ...
New FDA Chief Wants to Fast-Track Some Drugs, Use More AI Commissioner Marty Makary faces declining staff morale as he remakes agency By Liz Essley Whyte Share Resize ...
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help agency staff in drug clinical evaluations and reviews. FDA Artificial ...
FDA announces a new priority review program in bid to further administration goals Recipients can expect the agency to render decisions within 1-2 months Sarah Silbiger/Getty Images By Lizzy Lawrence ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax ...